|
WO2011044638A1
|
|
Method of treatment of liver disease
|
|
AU2005256173A1
|
|
Composition and method for treatment and prevention of atherosclerosis
|
|
WO2006000052A1
|
|
Composition and method for treatment and prevention of atherosclerosis
|
|
CN1946408A
|
|
Pharmaceutical composition of liver disease
|
|
WO2005102353A1
|
|
Supportive treatment of liver disease
|
|
CA2535451A1
|
|
Method of treating viral infections
|
|
MY128724A
|
|
Liver selective theraphy.
|
|
AU2988901A
|
|
Liver-selective chemotherapy
|
|
WO0132162A1
|
|
Liver selective therapy
|
|
AUPQ547100A0
|
|
Liver selective therapy
|
|
AUPQ523600A0
|
|
Treatment of portal hypertension
|
|
AUPQ385599A0
|
|
Treatment of hypercholesterolaemia
|
